Cambridge Clinical Laboratories Acquired by Source BioScience
Source BioScience has acquired Cambridge Clinical Laboratories to expand its clinical diagnostics capabilities and enhance testing services.
Read MorePosted by Chris Wolski | Apr 10, 2025 | Company News |
Source BioScience has acquired Cambridge Clinical Laboratories to expand its clinical diagnostics capabilities and enhance testing services.
Read MorePosted by Chris Wolski | Apr 8, 2025 | Company News |
NeoGenomics has acquired Pathline, LLC to strengthen its presence in the Northeast U.S. and accelerate growth in oncology testing services.
Read MorePosted by Chris Wolski | Apr 1, 2025 | Sexually Transmitted Diseases |
Mpox is evolving into a significant global health threat due in part to limited diagnostic tools and treatments.
Read MorePosted by Chris Wolski | Mar 28, 2025 | Sequencing Systems |
Thermo Fisher Scientific has launched the One Lambda HybriType HLA Plus Typing Flex kit, an NGS hybrid capture assay.
Read MorePosted by Chris Wolski | Mar 26, 2025 | Molecular Diagnostics |
Thermo Fisher Scientific introduces the SeqStudio Flex Dx Genetic Analyzer, an IVDR-compliant capillary electrophoresis system.
Read More